Filing Details
- Accession Number:
- 0001209191-17-065896
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-15 16:09:01
- Reporting Period:
- 2017-12-13
- Accepted Time:
- 2017-12-15 16:09:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578408 | Nick Leschly | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-12-13 | 37,873 | $5.50 | 293,232 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-12-13 | 14,947 | $181.72 | 278,285 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-13 | 27,797 | $182.49 | 250,488 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-13 | 19,221 | $183.46 | 231,267 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-13 | 18,930 | $184.53 | 212,337 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-13 | 16,369 | $185.41 | 195,968 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-13 | 12,006 | $186.56 | 183,962 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-13 | 5,700 | $187.57 | 178,262 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-12-13 | 2,530 | $188.49 | 175,732 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2017-12-13 | 37,873 | $0.00 | 37,873 | $5.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
203,355 | 2023-01-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 17,186 | Indirect | Nick Leschly 2001 Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- The range of prices for the transaction reported on this line was $181.0500 to $182.0000. The average weighted price was $181.7220. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $182.0500 to $183.0000. The average weighted price was $182.4893. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $183.0500 to $184.0000. The average weighted price was $183.4565. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $184.0500 to $185.0000. The average weighted price was $184.5288. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $185.0500 to $186.0000. The average weighted price was $185.4139. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $186.0500 to $187.0000. The average weighted price was $186.5618. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $187.0500 to $188.0000. The average weighted price was $187.5675. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $188.1500 to $188.8000. The average weighted price was $188.4907. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option to purchase shares of our common stock was granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.